Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Enzo Biochem, Inc. (ENZ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.3100+0.0600 (+1.85%)
At close: 04:00PM EST
3.3100 0.00 (0.00%)
After hours: 07:20PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.2500
Open3.2400
Bid3.0800 x 800
Ask3.8000 x 1200
Day's Range3.1800 - 3.3700
52 Week Range2.6100 - 4.8500
Volume113,743
Avg. Volume168,066
Market Cap160.442M
Beta (5Y Monthly)0.84
PE Ratio (TTM)33.10
EPS (TTM)0.1000
Earnings DateMar 14, 2022 - Mar 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GuruFocus.com

    Corrado Advisors, Llc Buys Innovator Emerging Markets Power Buffer ETF - Octo, Innovator ...

    Investment company Corrado Advisors, Llc (Current Portfolio) buys Innovator Emerging Markets Power Buffer ETF - Octo, Innovator International Developed Power Buffer ETF, iShares Core S&P Total U.S.

  • GlobeNewswire

    Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem’s Board of Directors

    NEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointments of Hamid Erfanian and Bradley Radoff to the Company’s Board of Directors (the “Board”), effective immediately. The Company also announced that directors Dov Perlysky and Rebecca Fischer will step down from the Board immediately to facilitate a smooth transition for the new Board members. Dr. Mary Tagliaferri will

  • GlobeNewswire

    Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update

    1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing a 7% sequential increaseCompany appoints Hamid Erfanian as Chief Executive Officer Consolidated manufacturing footprint at state-of-the-art Farmingdale, NY campus to enhance operational efficiencies Conference call and live webcast scheduled for today,Wednesday, December 15, 2021 at 4:30 pm (ET) NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company

Advertisement
Advertisement